Status:
UNKNOWN
Intestinal Microbiota of Breast Cancer Patients Undergoing Chemotherapy
Lead Sponsor:
First Affiliated Hospital of Harbin Medical University
Conditions:
Microbiota
Eligibility:
FEMALE
18-65 years
Brief Summary
To date, few studies have addressed the link between gut microbiota and breast cancer chemotherapy, and previous studies have only provided a link between the gut and breast cancer.
Detailed Description
To date, few studies have addressed the link between gut microbiota and breast cancer chemotherapy, and previous studies have only provided a link between the gut and breast cancer.At present, studies...
Eligibility Criteria
Inclusion
- Aged 18 to 65 years
- First use of chemotherapy after breast cancer
Exclusion
- Pregnancy
- Lactation
- Cigarette smoking
- Alcohol addiction
- Hypertension
- Diabetes mellitus
- Lipid dysregulation
- BMI \> 27
- Recent (\< 3 months prior) use of antibiotics, probiotics, prebiotics, symbiotics, hormonal medication, laxatives, proton pump inhibitors, insulin sensitizers or Chinese herbal medicine
- History of disease with an autoimmune component, such as MS, rheumatoid arthritis, IBS, or IBD
- History of malignancy or any gastrointestinal tract surgery
Key Trial Info
Start Date :
September 12 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 15 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04138979
Start Date
September 12 2019
End Date
October 15 2020
Last Update
October 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First affiliated hospital of Harbin medical university
Harbin, Heilongjiang, China, 150001